Effects on in vitro replication of equine infectious anemia virus attenuated vaccine strain with truncated mutation in the transmembrane protein

Progress in Biochemistry and Biophysics

Volumn 37, Issue 3, 2010, Pages 261-268

  Jiang, Cheng Gang ^a,b   Ma, Jian ^a   Gao, Xu ^a,d   Lin, Yue Zhi ^a   Zhao, Li Ping ^a   Hua, Yu Ping ^c   Liu, Di ^b   Zhou, Jian Hua ^a  

^a INSTITUTE OF PLANT PROTECTION   (China)

^b HEILONGJIANG ACADEMY OF AGRICULTURAL SCIENCES   (China)

^c NORTHEAST FORESTRY UNIVERSITY   (China)

^d YANBIAN UNIVERSITY   (China)

Author keywords

Apoptosis; Equine infectious anemia virus; Gp45 transmembrane protein; Replication; Truncated mutation

Indexed keywords

EQUIDAE; EQUINE INFECTIOUS ANEMIA VIRUS; EQUUS ASINUS;

EID: 77951228673     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: 10.3724/SP.J.1206.2009.00595     Document Type: Article

References (20)

1. Craigo J K, Li F, Steckbeck J D, et al. Discerning an effective balance between equine infectious anemia virus attenuation and vaccine Efficacy. J Virol, 2005, 79(5): 2666-2677
2. Wodarz D. Immunity and protection by live attenuated HTV/SIV vaccines. Virology, 2008, 378(2): 299-305
3. Miller C J, Mcchesney M B, Lu X, et al. Rhesus macaques previously infected with simian/human immunodeficiency virus are protected from vaginal challenge with pathogenic SIVmac239. J Virol, 1997, 71(3): 1911-1921
4. Mori K, Sugimoto C, Ohgimoto S, et al. Influence of glycosylation on the efficacy of an env-based vaccine against simian immunodeficiency virus SIVmac239 in a macaque AIDS model. J Virol, 2005, 79(16): 10386-10396
5. Wodarz D. Immunity and protection by live attenuated HTV/SIV vaccines. Virology, 2008, 378(2): 299-305
6. Tagmyer T L, Craigo J K, Cook S J, et al. Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition. J Virol, 2008, 82 (2): 4052-4063
7. Asquith B. The evolutionary selective advantage of HIV-1 escape variants and the contribution of escape to the HLA-associated risk of AIDS progression. PLoS ONE, 2008, 3(10): e3486
8. Howe L, Leroux C, Issel C J, et al. Equine infectious anemia virus envelope evolution in vivo during persistent infection progressively increases resistance to in vitro serum antibody neutralization as a dominant phenotype. J Virol, 2002, 76(21): 10588-10597
9. Zwick M B, Labrijn A F, Wang M, et al. Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41. J Virol, 2001, 75(22): 10892-10905
10. Micoli K J, Mamaeva O, Piller S C, et al. Point mutations in the C-terminus of HIV-1 gp160 reduce apoptosis and calmodulin binding without affecting viral replication. J Virol, 2006, 344(2): 468-479
11. Costin J M. Cytopathic mechanisms of HIV-1. Virology J, 2007, 4(100): 100-122
12. Chong Y H, Ball J M, Issel C J, et al. Analysis of equine humoral immune responses to the transmembrane envelope glycoprotein (gp45) of equine infectious anemia virus. J Virol, 1991, 65(2):1013-1018
13. Waheed A A, Ablan S D, Roser J D, et al. HIV-1 escape from the entry-inhibiting effects of a cholesterol-binding compound via cleavage of gp41 by the viral protease. Proc Natl Acad Sci USA, 2007, 104(20): 8467-8471
14. Shang L, Yue L, Hunter E, et al. Role of the membrane-spanning domain of human immunodeficiency virus type 1 envelope glycoprotein in cell-cell fusion and virus infection. J Virol, 2008, 82(11): 5417-5428
15. Thomson B J. Viruses and apoptosis. Int J Exp Pathol, 2001, 82(2): 65-76
16. κB dependent, HIV replicationthat requires procaspase 8. PLOS ONE, 2009, 4(3): e4875
17. Micoli K J, Mamaeva O, Piller S C, et al. Point mutations in the C-terminus of HIV-1 gp160 reduce apoptosis and calmodulin binding without affecting viral replication. Virology, 2006, 344(2): 468-479
18. Meng Q L, Li S W, Liu L X, et al. Truncation of cytoplasmic tail of EIAV Env increases the pathogenic necrosis. Virus Res, 2008, 2(133): 201-210
19. Jones D R, Suzuki K, Piller S C.A 100-amino acid truncation in the cytoplasmic tail of glycoprotein 41 in the reference HIV type 1 strain RF. AIDS Research and Human Retroviruses, 2002, 18(7): 513-517
20. Shacklett B L, Shaw K E S, Adamson L A, et al. Live, attenuated simian immunodeficiency virus SIVmac-M4, with point mutations in the env transmembrane protein intracytoplasmic domain, provides partial protection from mucosal challenge with pathogenic SIVmac251. J Virol, 2002, 76(22): 11365-11378